Page last updated: 2024-10-26

thiorphan and Aortic Diseases

thiorphan has been researched along with Aortic Diseases in 1 studies

Thiorphan: A potent inhibitor of membrane metalloendopeptidase (ENKEPHALINASE). Thiorphan potentiates morphine-induced ANALGESIA and attenuates naloxone-precipitated withdrawal symptoms.

Aortic Diseases: Pathological processes involving any part of the AORTA.

Research Excerpts

ExcerptRelevanceReference
"However, cardiac hypertrophy itself poses a serious risk to patients with heart failure."1.30Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model. ( Kimura, M; Nakashima, M; Ohashi, K; Umemura, K, 1998)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kimura, M1
Umemura, K1
Ohashi, K1
Nakashima, M1

Other Studies

1 other study available for thiorphan and Aortic Diseases

ArticleYear
Effect of ecadotril, a neutral endopeptidase inhibitor, on myocardial hypertrophy in the rat aortic insufficiency model.
    The Canadian journal of cardiology, 1998, Volume: 14, Issue:1

    Topics: Angiotensin II; Animals; Aortic Diseases; Blood Pressure; Cardiomegaly; Disease Models, Animal; Guan

1998